Oscar Health, Inc.
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Oscar Health Raises 2026 Operating Earnings Outlook as Margins Improve
Oscar Health raises its 2026 operating earnings outlook to $500M-$700M as pricing gains and tech efficiencies lift margins, despite rising churn and medical costs.
Is Oscar Health Stock a Buy as Growth Surges but Valuation Stays Rich?
Oscar Health's surging revenue, membership gains and improving profitability bolster its growth story, but premium valuation and churn risks cloud its outlook.
Oscar Health Rallies 14.9% in 3 Months: Can the Gains Keep Going?
Oscar Health shares have surged 14.9% in three months, fueled by membership growth, better underwriting and cost efficiencies. Can the rally continue?
Raymond James Updates Healthcare Top Picks for October
Investing.com -- Raymond James has updated its Healthcare Top Picks list for October, adding three new stocks while removing others from the monthly selection. The firm added Xencor, Calyxt, and UnitedHealth Group to replace Relay Therapeutics, Tyra Biosciences, and Oscar Health.
Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know
A number of stocks jumped in the morning session after Morningstar reported that challenging macroeconomic conditions across broader equity markets drove a rotation into healthcare, lifting the sector index by approximately 7% quarter-to-date to reach a 5% valuation premium.
CVS Still Sees 'High-Trend' Cost Growth; Oscar, UNH Stock Fall
CVS Health noted a continuation of "high-trend" medical cost growth at a Wells Fargo investor conference on Wednesday, helping to put a spring in the step of hospital stocks including HCA Healthcare, while souring the mood of managed care investors. Shares of CVS stock came away relatively unscathed, while UnitedHealth slipped and Oscar Health stumbled. CVS management's comments about medical cost trends were brief and vague, while Wells Fargo conference presentations by HCA and Universal Health Services didn't appear to provide updates to Q3 trends since Q2 earnings calls.
Oscar Health Stock Sinks Amid This Second-Half Risk
Oscar Health dived Thursday morning, despite reporting better-than-expected earnings and raising its full-year outlook. Oscar said it sees more tailwinds than headwinds based on what it knows. Shifts in the ACA Marketplace due to the surge in premiums related to the end of enhanced government subsidies have transformed the market.
Nike downgraded, Oscar Health upgraded: Wall Street's top analyst calls
Nike downgraded, Oscar Health upgraded: Wall Street's top analyst calls
Congressional Trades in $OSCR
No disclosed congressional trades found in $OSCR.
Insider Trades (Form 4)
Plouffe David
Sankaran Sid
Gassen William
Kushner Joshua
Thrive Partners VII Growth GP, LLC
Key People
Plouffe David
Director
Sankaran Sid
Director
Gassen William
Director
Kushner Joshua
Co-Founder and Vice Chairman
Thrive Partners VII Growth GP LLC
Director
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro